PetMed Express/$PETS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About PetMed Express
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Ticker
$PETS
Sector
Primary listing
Industry
Specialty Retail
Headquarters
Employees
287
ISIN
US7163821066
Website
PetMed Express Metrics
BasicAdvanced
$64M
182.84
$0.02
0.70
-
Price and volume
Market cap
$64M
Beta
0.7
52-week high
$6.16
52-week low
$2.90
Average daily volume
136K
Financial strength
Current ratio
1.426
Quick ratio
1.092
Long term debt to equity
0.678
Total debt to equity
1.149
Dividend payout ratio (TTM)
54.34%
Profitability
EBITDA (TTM)
8.227
Gross margin (TTM)
27.68%
Net profit margin (TTM)
0.14%
Operating margin (TTM)
0.96%
Effective tax rate (TTM)
81.36%
Revenue per employee (TTM)
$860,000
Management effectiveness
Return on assets (TTM)
0.93%
Return on equity (TTM)
0.36%
Valuation
Price to earnings (TTM)
182.841
Price to revenue (TTM)
0.26
Price to book
0.67
Price to tangible book (TTM)
1.08
Price to free cash flow (TTM)
74.98
Free cash flow yield (TTM)
1.33%
Free cash flow per share (TTM)
4.16%
Growth
Revenue change (TTM)
-10.82%
Earnings per share change (TTM)
-113.05%
3-year revenue growth (CAGR)
-3.99%
10-year revenue growth (CAGR)
0.80%
3-year earnings per share growth (CAGR)
-74.90%
10-year earnings per share growth (CAGR)
-32.35%
What the Analysts think about PetMed Express
Analyst ratings (Buy, Hold, Sell) for PetMed Express stock.
PetMed Express Financial Performance
Revenues and expenses
PetMed Express Earnings Performance
Company profitability
PetMed Express News
AllArticlesVideos
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
GlobeNewsWire·7 hours ago
PETMED INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm
GlobeNewsWire·3 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
GlobeNewsWire·4 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PetMed Express stock?
PetMed Express (PETS) has a market cap of $64M as of July 18, 2025.
What is the P/E ratio for PetMed Express stock?
The price to earnings (P/E) ratio for PetMed Express (PETS) stock is 182.84 as of July 18, 2025.
Does PetMed Express stock pay dividends?
No, PetMed Express (PETS) stock does not pay dividends to its shareholders as of July 18, 2025.
When is the next PetMed Express dividend payment date?
PetMed Express (PETS) stock does not pay dividends to its shareholders.
What is the beta indicator for PetMed Express?
PetMed Express (PETS) has a beta rating of 0.7. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.